Cat. No. 5446
Chemical Name: 3-(3,4,5-Trihydroxybenzoyloxy)napht
Biological ActivityFASN inhibitor. Inhibits breast cancer cell proliferation in vitro (IC50 values are 21 - 79 μM), including cell lines resistant to anti-HER2 therapies. Blocks HER2 signaling and induces apoptosis. Inhibits growth of breast cancer xenografts in mice without causing anorexia.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Puig et al (2011) A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines. Breast Cancer Res. 13 R131. PMID: 22177475 .
Puig et al (2009) Novel inhibitors of fatty acid synthase with anticancer activity. Clin.Cancer Res. 15 7608. PMID: 20008854.
If you know of a relevant reference for G 28UCM please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses G 28UCM from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: G 28UCM, supplier, G28UCM, fatty, acid, synthase, inhibitors, inhibits, FASN, breast, cancer, Tocris Bioscience, Fatty Acid Synthase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Highly potent and SAM-competitive EZH2 inhibitorGSK 591 dihydrochloride
Potent and selective PRMT5 inhibitorTP 064
Potent and selective PRMT 4 inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.